The National Center for Toxicological Research (NCTR) is an important research component of the FDA that plays a critical role in the missions of FDA and DHHS to promote and protect public health.
NCTR—in partnership with researchers from government, academia, and industry—develops, refines, and applies current and emerging technologies to improve safety evaluations of FDA-regulated products.
NCTR fosters national and international collaborations to improve and protect public health and enhance the quality of life for the American people. Through the training of scientists from around the world, as well as FDA staff, NCTR researchers spread the principles of regulatory science globally.
NCTR conducts FDA research with the goal to develop a scientifically sound basis for regulatory decisions and reduce risks associated with FDA-regulated products. NCTR represents the FDA on key committees of the National Toxicology Program (NTP), a program that evaluates the effects of chemicals on health. Over the past 30 years, the NTP and NCTR have conducted studies on FDA-nominated compounds, providing data to support science-based regulatory decisions.
Learn More About NCTR's Research Accomplishments and Plans
NCTR in the Press ...
BPA and Babies: New Research From FDA Focuses On What Happens In Womb FDA, state of Arkansas sign agreement to advance regulatory science[ARCHIVED] Feds Reject Petition To Ban BPA In Food Landmark Birthday for FDA Research Center[ARCHIVED] Leading Environmental Group Scientist Praises FDA's Ground-Breaking Research On BPA: A Tipping Point In The Controversy Little Rock firm develops rapid test for E. coli bacteria Today's THV takes you inside the National Center for Toxicological Research Unraveling the Microbiome US Lead in Nanotechnology Depends on Growth of FDA and Government Initiiatives